Mahmood Araghi

Mahmood Araghi

Auto-generated profile, based on publicly available information

Mahmood Araghi

Department of Pathology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2023 in EXCLI Journal
Verified
Journal Article
Open access
MAMina Alimohammadi
Mina Alimohammadi
YGYasaman Gholinezhad
Yasaman Gholinezhad
VMVahide Mousavi
Vahide Mousavi
SKSamaneh Kahkesh
Samaneh Kahkesh
MRMalihe Rezaee
Malihe Rezaee
MAMahmood Araghi
Mahmood Araghi
Circular RNAs (CircRNAs) are a class of regulatory RNA transcripts, which are ubiquitously expressed in eukaryotes. CircRNA dysregulation has been shown to disrupt the interaction of the Wnt/β-catenin pathway, which regulates several biological processes involved in tumorigenesis, thereby contributing to the development and progression of cancer. Interactions of tumor-derived circRNAs with the Wnt/β-catenin signaling pathway provide both clinical diagnostic biomarkers and promising therapeutic targets. In this review, we outlined current evidence on the roles of circRNAs associated with the Wnt/β-catenin pathway in regulating lung cancer formation and development. We believe that our findings will assist in the advancement or establishment of circRNA-based lung cancer therapeutic approaches.

30 September 2011 in Clinical Biochemistry
Verified
Journal Article
Closed access
MMMaryam Mousavi
Maryam Mousavi
MAMahmood Araghi
Mahmood Araghi
AKAkbar Karimi
Akbar Karimi
DZDavoud Ghoil Zadeh
Davoud Ghoil Zadeh

31 August 2015 in International Journal of Advances in Biology
Verified
Journal Article
Closed access
MMMaryam Mousavi
Maryam Mousavi
HGHooria Seyedhosseini Ghaheh
Hooria Seyedhosseini Ghaheh
RRReza Rasoolzadeh
Reza Rasoolzadeh
MAMahmood Araghi
Mahmood Araghi

1 January 2015 in Advanced Biomedical Research
Verified
Journal Article
Open access
PDF file
MMMaryam Mousavi
Maryam Mousavi
HGHooria Seyedhosseini Ghaheh
Hooria Seyedhosseini Ghaheh
MAMahmood Araghi
Mahmood Araghi
RRReza Rasoolzadeh
Reza Rasoolzadeh
ZHZahra Hosseini
Zahra Hosseini
Background: Influenza H1N1 is very important worldwide and point mutations that occur in the virus gene are a threat for the World Health Organization (WHO) and druggists, since they could make this virus resistant to the existing antibiotics. Influenza epidemics cause severe respiratory illness in 30 to 50 million people and kill 250,000 to 500,000 people worldwide every year. Nowadays, drug design is not done through trial and error because of its cost and waste of time; therefore bioinformatics studies is essential for designing drugs. Materials and Methods: This paper, infolds a study on binding site of Neuraminidase (NA) enzyme, (that is very important in drug design) in 310K temperature and different dielectrics, for the best drug design. Information of NA enzyme was extracted from Protein Data Bank (PDB) and National Center for Biotechnology Information (NCBI) websites. The new sequences of N1 were downloaded from the NCBI influenza virus sequence database. Drug binding sites were assimilated and homologized modeling using Argus lab 4.0, HyperChem 6.0 and Chem. D3 softwares. Their stability was assessed in different dielectrics and temperatures. Result: Measurements of potential energy (Kcal/mol) of binding sites of NA in different dielectrics and 310K temperature revealed that at time step size = 0 pSec drug binding sites have maximum energy level and at time step size = 100 pSec have maximum stability and minimum energy. Conclusions: Drug binding sites are more dependent on dielectric constants rather than on temperature and the optimum dielectric constant is 39/78.